IN20-01b

Main Content

Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with Precursor B-Cell ALL: A CIBMTR Analysis

Study #: IN20-01b

Study Status: Published

Real-world outcomes of infections following Tisagenlecleucel in patients with B-cell ALL: A CIBMTR analysis.

Citation

Rangarajan HG, Satwani P, Herr MM, Chen M, Martens MJ, Wudhikarn K, John S, Fabrizio VA, Hsieh EM, Kelkar AH, Doherty E, Marks DI, Ringden O, Friend BD, Kelly MS, Farhadfar N, Prestidge T, Hossain NM, Liu H, Hashmi S, Modi D, Winestone LE, El Boghdadly Z, Murthy HS, Perales MA, Chemaly RF, Dandoy CE, Hill JA, Huppler AR, Riches M, Auletta JJ.

Blood Advances. 2025, Nov 11: 9(21): 9(21):5489-5500. doi: 10.1182/bloodadvances.2025016149. Epub 2025, Jul 30. PMCID:PMC12607035.

PubMed

PMID: 40737539

Abstract